135 related articles for article (PubMed ID: 2170079)
1. Cytomegalovirus pneumonia in allogeneic bone marrow transplantation. An immunopathologic process?
Chien J; Chan CK; Chamberlain D; Patterson B; Fyles G; Minden M; Meharchand J; Messner H
Chest; 1990 Oct; 98(4):1034-7. PubMed ID: 2170079
[TBL] [Abstract][Full Text] [Related]
2. Long-term sequelae after recovery from cytomegalovirus pneumonia in allogeneic bone marrow transplant recipients.
Chien SM; Chan CK; Kasupski G; Chamberlain D; Fyles G; Messner H
Chest; 1992 Apr; 101(4):1000-4. PubMed ID: 1313348
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus pneumonia prior to engraftment following T-cell depleted bone marrow transplantation.
Nagler A; Elishoov H; Kapelushnik Y; Breuer R; Or R; Engelhard D
Med Oncol; 1994; 11(3-4):127-32. PubMed ID: 7633832
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of cytomegalovirus pneumonitis with ganciclovir and high-dose intravenous immunoglobulin in a bone marrow transplant recipient.
Chow JM; Lin MT; Chen YC; Chang SC; Su IJ; Tang JL
J Formos Med Assoc; 1992 Oct; 91(10):996-1000. PubMed ID: 1362680
[TBL] [Abstract][Full Text] [Related]
5. Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients.
Nguyen Q; Champlin R; Giralt S; Rolston K; Raad I; Jacobson K; Ippoliti C; Hecht D; Tarrand J; Luna M; Whimbey E
Clin Infect Dis; 1999 Mar; 28(3):618-23. PubMed ID: 10194088
[TBL] [Abstract][Full Text] [Related]
6. Ganciclovir and standard high-dose immunoglobulins for the treatment of cytomegalovirus interstitial pneumonia in a bone marrow recipient.
Iori AP; Gentile G; Petasecca Donati P; Arcese W; Martino P; Mandelli F
Haematologica; 1990; 75(4):394-6. PubMed ID: 2177441
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cytomegalovirus disease.
Emanuel D
Semin Hematol; 1990 Apr; 27(2 Suppl 1):22-7; discussion 28-9. PubMed ID: 2160128
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation.
de Medeiros CR; Moreira VA; Pasquini R
Bone Marrow Transplant; 2000 Aug; 26(4):443-4. PubMed ID: 10982292
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus seroconversion in patients receiving intensive induction therapy prior to allogeneic bone marrow transplantation.
Kelsey SM; Newland AC
Bone Marrow Transplant; 1989 Sep; 4(5):543-6. PubMed ID: 2551435
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of cytomegalovirus pneumonia in immunocompromised hosts.
Riddell SR
Semin Respir Infect; 1995 Dec; 10(4):199-208. PubMed ID: 8668847
[TBL] [Abstract][Full Text] [Related]
11. IL2 activated killer cells may contribute to cytomegalovirus induced marrow hypoplasia after bone marrow transplantation.
Duncombe AS; Grundy JE; Prentice HG; Brenner MK
Bone Marrow Transplant; 1991 Feb; 7(2):81-7. PubMed ID: 1646663
[TBL] [Abstract][Full Text] [Related]
12. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus is frequently isolated in bronchoalveolar lavage fluid of bone marrow transplant recipients without pneumonia.
Ruutu P; Ruutu T; Volin L; Tukiainen P; Ukkonen P; Hovi T
Ann Intern Med; 1990 Jun; 112(12):913-6. PubMed ID: 2160216
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection after autologous bone marrow transplantation with comparison to infection after allogeneic bone marrow transplantation.
Wingard JR; Chen DY; Burns WH; Fuller DJ; Braine HG; Yeager AM; Kaiser H; Burke PJ; Graham ML; Santos GW
Blood; 1988 May; 71(5):1432-7. PubMed ID: 2833959
[TBL] [Abstract][Full Text] [Related]
15. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT.
Trenschel R; Ross S; Hüsing J; Ottinger H; Elmaagacli A; Roggendorf M; Schaefer UW; Runde V
Bone Marrow Transplant; 2000 Mar; 25(6):665-72. PubMed ID: 10734302
[TBL] [Abstract][Full Text] [Related]
16. Virologic and pathogenetic aspects of cytomegalovirus infection.
Grundy JE
Rev Infect Dis; 1990; 12 Suppl 7():S711-9. PubMed ID: 2173100
[TBL] [Abstract][Full Text] [Related]
17. Bronchoalveolar lavage cell composition in allogeneic bone marrow transplant patients without symptomatic lung complications.
de la Cámara R; Girón R; Marrón C; Martínez C; Ancochea J; Fernández-Rañada JM; Aspa J
Bone Marrow Transplant; 1997 Dec; 20(12):1087-93. PubMed ID: 9466283
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cytomegalovirus immunoglobulin in marrow transplant recipients with cytomegalovirus pneumonia.
Reed EC; Bowden RA; Dandliker PS; Gleaves CA; Meyers JD
J Infect Dis; 1987 Oct; 156(4):641-5. PubMed ID: 3040870
[No Abstract] [Full Text] [Related]
19. A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants.
Verdonck LF; Dekker AW; Rozenberg-Arska M; van den Hoek MR
Clin Infect Dis; 1997 May; 24(5):901-7. PubMed ID: 9142790
[TBL] [Abstract][Full Text] [Related]
20. [Cytomegalovirus antigenemia in the differential diagnosis of pulmonary infiltrates after allogeneic bone marrow transplantation].
Gondo H; Harada M; Minematsu T; Akashi K; Hayashi S; Taniguchi S; Yamasaki K; Shibuya T; Takamatsu Y; Eto T
Rinsho Ketsueki; 1993 Nov; 34(11):1438-44. PubMed ID: 8254905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
